NCT05433116 2025-12-02Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCCUniversität des SaarlandesPhase 2 Active not recruiting50 enrolled
NCT05620134 2024-10-15Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerSalubris Biotherapeutics IncPhase 1/2 Active not recruiting263 enrolled